VIRGINIA RETIREMENT SYSTEMS ET Al Invests $3.33 Million in Indivior PLC $INDV

VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in Indivior PLC (NASDAQ:INDV) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 81,200 shares of the company’s stock, valued at approximately $3,332,000. VIRGINIA RETIREMENT SYSTEMS ET Al owned about 0.07% of Indivior as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in INDV. Caitong International Asset Management Co. Ltd grew its stake in shares of Indivior by 72.7% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,093 shares of the company’s stock valued at $39,000 after buying an additional 460 shares during the last quarter. Quarry LP bought a new position in shares of Indivior during the 3rd quarter worth approximately $26,000. Rockefeller Capital Management L.P. lifted its holdings in shares of Indivior by 512.4% during the 4th quarter. Rockefeller Capital Management L.P. now owns 1,286 shares of the company’s stock valued at $46,000 after purchasing an additional 1,076 shares during the last quarter. TD Waterhouse Canada Inc. acquired a new stake in Indivior in the second quarter worth about $63,000. Finally, GAMMA Investing LLC acquired a new position in shares of Indivior during the second quarter valued at about $66,000. Institutional investors own 60.33% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. Weiss Ratings upgraded shares of Indivior from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, September 4th. Zacks Research lowered Indivior from a “strong-buy” rating to a “hold” rating in a research report on Monday, June 29th. Craig Hallum reiterated a “buy” rating and issued a $53.00 price objective on shares of Indivior in a research note on Tuesday, August 4th. Finally, Barclays reduced their target price on shares of Indivior from $46.00 to $43.00 and set an “overweight” rating for the company in a report on Wednesday, August 5th. Six research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Indivior presently has an average rating of “Moderate Buy” and a consensus price target of $45.17.

Insider Activity at Indivior

In related news, CAO Woodrow D. Anderson acquired 1,500 shares of Indivior stock in a transaction that occurred on Thursday, August 27th. The shares were purchased at an average cost of $35.69 per share, for a total transaction of $53,535.00. Following the acquisition, the chief accounting officer owned 27,638 shares in the company, valued at approximately $986,400.22. This represents a 5.74% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Christian Heidbreder sold 18,586 shares of the company’s stock in a transaction dated Friday, July 10th. The shares were sold at an average price of $41.14, for a total transaction of $764,628.04. Following the completion of the transaction, the insider directly owned 209,337 shares in the company, valued at $8,612,124.18. The trade was a 8.15% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.74% of the company’s stock.

Indivior Stock Up 1.3%

Shares of NASDAQ INDV opened at $34.77 on Thursday. The firm has a 50-day simple moving average of $38.39 and a 200-day simple moving average of $36.04. The stock has a market capitalization of $4.10 billion, a price-to-earnings ratio of 12.46 and a beta of 0.82. Indivior PLC has a 52 week low of $22.22 and a 52 week high of $42.81.

Indivior (NASDAQ:INDV) last announced its quarterly earnings data on Tuesday, June 30th. The company reported $5.75 EPS for the quarter. The firm had revenue of $343.00 million for the quarter. Indivior had a negative return on equity of 283.11% and a net margin of 26.65%. As a group, equities research analysts expect that Indivior PLC will post 3.66 EPS for the current year.

Indivior Company Profile

Indivior plc is a specialty pharmaceutical company dedicated to developing and delivering treatments for addiction and related mental health disorders. The company’s portfolio centers on therapies designed to support individuals dealing with opioid dependence, alcohol use disorder and other behavioral health challenges. Its lead products include Suboxone® (buprenorphine and naloxone) sublingual film and Sublocade® (extended-release buprenorphine) injection, both of which are approved in multiple markets to aid in opioid use disorder management.

Indivior was established in 2014 through a demerger from the pharmaceuticals division of Reckitt Benckiser Group plc, inheriting decades of research and commercial expertise in addiction medicine.